Tag: iPSC
Stanford CVI Biobank: A Growing Library of Human iPSC Lines for Cardiovascular Research
Banking has been around for more than 4,000 years and involves saving and lending resources for personal and communal benefits. Biobanking, on the other hand, is a modern application of this historical concept, specifically in the field of medical...
Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products
Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage,...
GoodCell Launches Personal Biobanking to Store Members’ Stem Cells for Future Personalized Therapies
GoodCell, a life sciences company, launched Personal Biobanking, a proactive, preventative healthcare service that allows members to store their own stem cells for potential future personalized therapy.
Thousands of cell and gene therapies are in development to treat diseases and...
Allele Biotech to Collaborate with Cellatoz on Cell Therapy and iPSC Biobanking
Allele Biotechnology & Pharmaceuticals in San Diego, California, today announced the signing of a MOU with Cellatoz Therapeutics, a South Korean corporation, to form a business relationship on areas of mutual interest in the field of cell therapy.
iPSC-based cell...
IPS HEART Aims To Use Induced Pluripotent Stem Cells To Treat Heart Attack
IPS HEART is a privately-held biopharmaceutical company, founded in 2014, dedicated to addressing heart attack, heart failure and Duchenne cardiomyopathy via next generation cellular therapy. IPS HEART was the first company to exclusively focus on induced pluripotent stem cells...
